582 related articles for article (PubMed ID: 6243420)
21. gyrB-225, a mutation of DNA gyrase that compensates for topoisomerase I deficiency: investigation of its low activity and quinolone hypersensitivity.
Heddle JG; Lu T; Zhao X; Drlica K; Maxwell A
J Mol Biol; 2001 Jun; 309(5):1219-31. PubMed ID: 11399091
[TBL] [Abstract][Full Text] [Related]
22. DNA gyrase action involves the introduction of transient double-strand breaks into DNA.
Mizuuchi K; Fisher LM; O'Dea MH; Gellert M
Proc Natl Acad Sci U S A; 1980 Apr; 77(4):1847-51. PubMed ID: 6246508
[TBL] [Abstract][Full Text] [Related]
23. The mechanism of negative DNA supercoiling: a cascade of DNA-induced conformational changes prepares gyrase for strand passage.
Gubaev A; Klostermeier D
DNA Repair (Amst); 2014 Apr; 16():23-34. PubMed ID: 24674625
[TBL] [Abstract][Full Text] [Related]
24. Roles of topoisomerases in maintaining steady-state DNA supercoiling in Escherichia coli.
Zechiedrich EL; Khodursky AB; Bachellier S; Schneider R; Chen D; Lilley DM; Cozzarelli NR
J Biol Chem; 2000 Mar; 275(11):8103-13. PubMed ID: 10713132
[TBL] [Abstract][Full Text] [Related]
25. Mutations in the B subunit of Escherichia coli DNA gyrase that affect ATP-dependent reactions.
O'Dea MH; Tamura JK; Gellert M
J Biol Chem; 1996 Apr; 271(16):9723-9. PubMed ID: 8621650
[TBL] [Abstract][Full Text] [Related]
26. Mechanism of inhibition of DNA gyrase by cyclothialidine, a novel DNA gyrase inhibitor.
Nakada N; Gmünder H; Hirata T; Arisawa M
Antimicrob Agents Chemother; 1994 Sep; 38(9):1966-73. PubMed ID: 7811004
[TBL] [Abstract][Full Text] [Related]
27. Intrinsic DNA-dependent ATPase activity of reverse gyrase.
Shibata T; Nakasu S; Yasui K; Kikuchi A
J Biol Chem; 1987 Aug; 262(22):10419-21. PubMed ID: 3038879
[TBL] [Abstract][Full Text] [Related]
28. An atypical type II topoisomerase from Mycobacterium smegmatis with positive supercoiling activity.
Jain P; Nagaraja V
Mol Microbiol; 2005 Dec; 58(5):1392-405. PubMed ID: 16313624
[TBL] [Abstract][Full Text] [Related]
29. A model for the mechanism of strand passage by DNA gyrase.
Kampranis SC; Bates AD; Maxwell A
Proc Natl Acad Sci U S A; 1999 Jul; 96(15):8414-9. PubMed ID: 10411889
[TBL] [Abstract][Full Text] [Related]
30. Control of bacterial DNA supercoiling.
Drlica K
Mol Microbiol; 1992 Feb; 6(4):425-33. PubMed ID: 1313943
[TBL] [Abstract][Full Text] [Related]
31. The intrinsic ATPase of DNA gyrase.
Sugino A; Cozzarelli NR
J Biol Chem; 1980 Jul; 255(13):6299-306. PubMed ID: 6248518
[No Abstract] [Full Text] [Related]
32. Locking the ATP-operated clamp of DNA gyrase: probing the mechanism of strand passage.
Williams NL; Howells AJ; Maxwell A
J Mol Biol; 2001 Mar; 306(5):969-84. PubMed ID: 11237612
[TBL] [Abstract][Full Text] [Related]
33. The acidic C-terminal tail of the GyrA subunit moderates the DNA supercoiling activity of Bacillus subtilis gyrase.
Lanz MA; Farhat M; Klostermeier D
J Biol Chem; 2014 May; 289(18):12275-85. PubMed ID: 24563461
[TBL] [Abstract][Full Text] [Related]
34. Gyrase inhibitors and intracellular DNA supercoiling.
Franco RJ; Drlica K
Biochem Soc Trans; 1986 Apr; 14(2):499-501. PubMed ID: 3011555
[No Abstract] [Full Text] [Related]
35. Adenosine 5'-O-(3-thio)triphosphate (ATPgammaS) promotes positive supercoiling of DNA by T. maritima reverse gyrase.
Jungblut SP; Klostermeier D
J Mol Biol; 2007 Aug; 371(1):197-209. PubMed ID: 17560602
[TBL] [Abstract][Full Text] [Related]
36. An Escherichia coli DNA topoisomerase I mutant has a compensatory mutation that alters two residues between functional domains of the DNA gyrase A protein.
Oram M; Fisher LM
J Bacteriol; 1992 Jun; 174(12):4175-8. PubMed ID: 1317847
[TBL] [Abstract][Full Text] [Related]
37. Increase in synthesis and stability of sigma 32 on treatment with inhibitors of DNA gyrase in Escherichia coli.
Mizushima T; Ohtsuka Y; Mori H; Miki T; Sekimizu K
Mol Gen Genet; 1996 Dec; 253(3):297-302. PubMed ID: 9003316
[TBL] [Abstract][Full Text] [Related]
38. Crystal structures of Escherichia coli topoisomerase IV ParE subunit (24 and 43 kilodaltons): a single residue dictates differences in novobiocin potency against topoisomerase IV and DNA gyrase.
Bellon S; Parsons JD; Wei Y; Hayakawa K; Swenson LL; Charifson PS; Lippke JA; Aldape R; Gross CH
Antimicrob Agents Chemother; 2004 May; 48(5):1856-64. PubMed ID: 15105144
[TBL] [Abstract][Full Text] [Related]
39. Extensive regulation compromises the extent to which DNA gyrase controls DNA supercoiling and growth rate of Escherichia coli.
Jensen PR; Van Der Weijden CC; Jensen LB; Westerhoff HV; Snoep JL
Eur J Biochem; 1999 Dec; 266(3):865-77. PubMed ID: 10583380
[TBL] [Abstract][Full Text] [Related]
40. Positively supercoiled plasmid DNA is produced by treatment of Escherichia coli with DNA gyrase inhibitors.
Lockshon D; Morris DR
Nucleic Acids Res; 1983 May; 11(10):2999-3017. PubMed ID: 6304617
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
